Skip to content
ScienceDirrect

Journal of Taibah University Medical Sciences

Date: 29 September 2026

Volume 21, Issue 5 · Pages: 1126–1131

Show more⌄
Original Article● Open accessUnder a Creative Commons license ↗
Original Article

Menopausal symptom burden and response to hormone therapy in military-affiliated women: a prospective comparative cohort study

Show more⌄

Abstract

ObjectiveTo examine menopausal symptom burden and 12-week outcomes associated with hormone therapy in women with military obligations.Materials and methodsA prospective, non-randomised cohort included 186 women aged 40–50 years during 2023–2025. Hormone therapy was prescribed to 94 women; 92 received no hormone therapy. The Menopause Rating Scale (MRS) was assessed at baseline and 12 weeks. Reported…

Keywords
perimenopause; hormone therapy; Menopause Rating Scale; military-affiliated women; occupational stress; sleep

Authors and affiliations

A. D. Uro-Nile, M. G. Mukhamedova

Author affiliations are listed in the full article PDF.

Objective

To examine menopausal symptom burden and 12-week outcomes associated with hormone therapy in women with military obligations.

Materials and methods

A prospective, non-randomised cohort included 186 women aged 40–50 years during 2023–2025. Hormone therapy was prescribed to 94 women; 92 received no hormone therapy. The Menopause Rating Scale (MRS) was assessed at baseline and 12 weeks. Reported adjusted estimates and safety outcomes were extracted from the source research.

Results

Baseline MRS scores were higher in the hormone-therapy group, 18.4 ± 6.8 versus 14.2 ± 5.9. At 12 weeks, the respective scores were 10.2 ± 4.6 and 13.4 ± 5.7. The adjusted between-group difference was −5.9 points (95% CI −7.4 to −4.4; p < 0.001). A reduction of at least 30% occurred in 72 of 94 treated women (76.6%). Adverse effects were reported in 28.7%, and six women discontinued treatment. No serious adverse event was reported during the observation period.

Conclusion

Hormone therapy was associated with lower short-term symptom scores. Non-random allocation, baseline imbalance and limited safety follow-up prevent the observed difference from being interpreted as a definitive treatment effect or a long-term safety estimate.

Full article

Open the full article PDF

How to cite

A. D. Uro-Nile, M. G. Mukhamedova. (2026). Menopausal symptom burden and response to hormone therapy in military-affiliated women: a prospective comparative cohort study. Journal of Taibah University Medical Sciences, Volume 21, Issue 5, 1126–1131. Article ID: SDR-2026-0020.

All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
RELX